LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	WZ-4-145	0.04	uM	LJP6	72	hr	1657	4689	5505	0.8517	0.7879
BT-20	XMD16-144	0.04	uM	LJP5	72	hr	1657	5393	5505	0.9797	0.9709
BT-20	Brivanib	0.04	uM	LJP5	72	hr	1657	5266	5505	0.9565	0.9377
BT-20	Buparlisib	0.04	uM	LJP5	72	hr	1657	5689	5505	1.0334	1.0477
BT-20	BX-912	0.04	uM	LJP5	72	hr	1657	5063	5505	0.9197	0.8851
BT-20	Canertinib	0.04	uM	LJP6	72	hr	1657	4885	5505	0.8874	0.8389
BT-20	Celastrol	0.04	uM	LJP6	72	hr	1657	5828	5505	1.0587	1.0839
BT-20	CGP60474	0.04	uM	LJP5	72	hr	1657	5524	5505	1.0034	1.0049
BT-20	CGP60474	0.04	uM	LJP6	72	hr	1657	1217	5505	0.2211	-0.1145
BT-20	CHIR-99021	0.04	uM	LJP6	72	hr	1657	5553	5505	1.0087	1.0124
BT-20	CP724714	0.04	uM	LJP5	72	hr	1657	5207	5505	0.9459	0.9226
BT-20	CP466722	0.04	uM	LJP5	72	hr	1657	5939	5505	1.0788	1.1127
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1657	4615	5505	0.8384	0.7687
BT-20	Momelotinib	0.04	uM	LJP5	72	hr	1657	4869	5505	0.8844	0.8345
BT-20	Dasatinib	0.04	uM	LJP5	72	hr	1657	5156	5505	0.9365	0.9091
BT-20	Dasatinib	0.04	uM	LJP6	72	hr	1657	2745	5505	0.4986	0.2826
BT-20	Dovitinib	0.04	uM	LJP5	72	hr	1657	4715	5505	0.8565	0.7947
BT-20	Enzastaurin	0.04	uM	LJP5	72	hr	1657	6123	5505	1.1122	1.1605
BT-20	Erlotinib	0.04	uM	LJP5	72	hr	1657	4819	5505	0.8753	0.8216
BT-20	Foretinib	0.04	uM	LJP5	72	hr	1657	5724	5505	1.0397	1.0568
BT-20	R406	0.04	uM	LJP6	72	hr	1657	5812	5505	1.0556	1.0796
BT-20	Pictilisib	0.04	uM	LJP6	72	hr	1657	4409	5505	0.8009	0.7151
BT-20	Gefitinib	0.04	uM	LJP6	72	hr	1657	5762	5505	1.0466	1.0667
BT-20	Geldanamycin	0.04	uM	LJP5	72	hr	1657	2646	5505	0.4806	0.2568
BT-20	Geldanamycin	0.04	uM	LJP6	72	hr	1657	2703	5505	0.4910	0.2716

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)